Paul D'Sylva

Overview

Paul D'Sylva received $269K in total compensation, including $157K in salary, at HedgePath Pharmaceuticals in 2007.

Source: SEC filing on October 30, 2008.

Related executives

We found five more executives who work or worked at HedgePath Pharmaceuticals.

Nicholas Virca

HedgePath Pharmaceuticals

Chief Executive Officer

Garrison Hasara

HedgePath Pharmaceuticals

Chief Financial Officer

Richard Freer

HedgePath Pharmaceuticals

Chief Operating Officer

Robert Harris

HedgePath Pharmaceuticals

President

Thomas Reynolds

HedgePath Pharmaceuticals

Senior Vice President

You may also like